Search

everythinglearnresearchcommunity

for

Search:↓

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Using psychological treatments can help manage skin conditions along with regular medical care.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Many skin patients also have mental health issues, and doctors should treat both together.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Trichotillomania in dementia may be better treated with dopamine blockers like quetiapine than with SSRIs.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

Bupropion SR may help treat trichotillomania.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Teak leaf extract contains compounds that could help treat hair loss.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

OR-101 shows promise for treating alopecia areata by improving hair growth.

The antidepressant escitalopram likely caused hair loss in a patient.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Some common medications can harm male fertility, but many effects can be reversed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Some blood pressure medications are linked to a higher risk of skin cancer.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Some drugs may reduce prostatitis symptoms short-term with few side effects.